IMPACT OF OZANIMOD (OZA) ON INTERLEUKIN-17A (IL-17A) LEVELS AND THE ASSOCIATION WITH OZA EFFICACY IN PATIENTS (PTS) WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (UC): RESULTS FROM THE PHASE 3 TRUE NORTH (TN) STUDY

Sarah Harris  ¹     Rachel Maddux     Chun Wu     Yanhua Hu     AnnKatrin Petersen     Severine Vermeire  ^2    
1 Bristol Myers Squibb, Princeton, United States
² University of Leuven, Leuven, Belgium

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)